Physician profile
Mark Jacobson
NPI 1760551915
$2,329.38
in general payments reported to CMS, 2019-2025
28 companies · $504 in 2025
The $504 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $850 · 2020: $260 · 2021: $322 · 2022: $143 · 2023: $143 · 2024: $108 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $487 · Long Term Medical Supply Or Device Loan: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $486.59 |
| Long Term Medical Supply Or Device Loan | $268.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $550.37 | 2019-2025 | Gamma, Mako |
| Integra Lifesciences Corporation | $333.87 | 2021-2025 | Integra, Micromatrix |
| Depuy Synthes Sales INC. | $250.47 | 2019-2021 | |
| Smith+Nephew, INC. | $221.50 | 2021-2025 | Katalyst Bipolar Radial Head System, Evos, Aetos Shoulder System |
| Zimmer Biomet Holdings, INC. | $170.03 | 2020 | |
| Globus Medical, INC. | $85.80 | 2023 | Clavicular Fracture Fixation, Proximal Humerus Strut |
| Bioventus LLC | $81.67 | 2019-2025 | Xcell |
| Pacira Pharmaceuticals Incorporated | $69.48 | 2019-2020 | |
| Allergan, INC. | $62.80 | 2019 | |
| Catalyst Orthoscience | $56.91 | 2025 | |
| Pacira Therapeutics, INC. | $50.87 | 2019-2021 | |
| Heron Therapeutics, INC. | $45.25 | 2021-2022 | |
| Convatec INC. | $34.67 | 2019-2023 | |
| Nevro Corp. | $32.33 | 2022 | |
| Endo Pharmaceuticals INC. | $29.35 | 2019-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $27.94 | 2020 | |
| Anika Therapeutics, INC. | $27.62 | 2021 | |
| Bard Peripheral Vascular, INC. | $27.09 | 2021 | |
| Abbvie INC. | $23.87 | 2021 | |
| Acera Surgical, INC. | $21.65 | 2023 | Restrata Wound Matrix |
| Kerecis Limited | $19.37 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Djo, LLC | $18.56 | 2019 | |
| Trevena, INC. | $17.10 | 2022 | |
| Arthrosurface Incorporated | $15.97 | 2020 | |
| Avanos Medical | $15.06 | 2019 | |
| Baudax Bio INC. | $14.11 | 2020 | |
| Ermi LLC | $13.04 | 2020 | |
| Acell, INC. | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Jacobson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.